Skip to main content
Clinical Trials/ACTRN12606000307505
ACTRN12606000307505
Completed
Phase 3

Fetal intrapartum pulse oximetry to reduce operative delivery rates in the presence of a non-reassuring fetal heart rate: a multicentre randomised controlled trial (the FOREMOST trial).

Royal Brisbane and Women's Hospital, The University of Queensland,Perinatal Research Centre0 sites600 target enrollmentMarch 6, 2001

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
on-reassuring fetal status during labour
Sponsor
Royal Brisbane and Women's Hospital, The University of Queensland,Perinatal Research Centre
Enrollment
600
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 6, 2001
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Royal Brisbane and Women's Hospital, The University of Queensland,Perinatal Research Centre

Eligibility Criteria

Inclusion Criteria

  • Women in labour at \> or \= 36 weeks gestation with a non\-reasuring CTG pattern.

Exclusion Criteria

  • Multiple gestation; non\-vertex presentation; placenta praevia; abrnp? placenta; APH; fetal anomaly; known significant viral infection (eg HIV); contraindication to invasive fetal monitoring

Outcomes

Primary Outcomes

Not specified

Similar Trials